News
Roche's Thomas Schinecker

Vabysmo vaults into Roche’s top growth spot

The undisputed star of Roche’s pharma portfolio in the first quarter of this year is eye disease therapy Vabysmo, heading for blockbuster territory after posting sales of

News
Biogen gets FDA approval for ALS drug Qalsody

Biogen gets FDA approval for ALS drug Qalsody

After much deliberation, the FDA has granted accelerated approval for Biogen’s tofersen for an ultra-rare form of the neurodegenerative disease amyotrophic lateral scleros

News

Press Releases

Views & Analysis

Newsletters and Deep Dive
digital magazine

Deep Dive

Webinars

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png
Sales & Marketing
Abstract visual of head
Sponsored

Health Trends 2025: Reimagining What's Possible

Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl

Podcasts

Video

Sales & Marketing
Interview with Craig Ackerman Reuters at Pharma USA 2026

Biotech is back, with Craig Ackerman

In Philadelphia last month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.

White Papers

Sales & Marketing
5 strategies to retain top talent download banner
Sponsored

5 strategies to retain top talent

The pharma sales industry is in the midst of rapid transformation, fuelled by digital disruption and dynamic market forces.

Event

Debates & Insight

Debates & Insight
Digital-HCP-engagement-1200x675
Sponsored

How to optimise pharma’s digital HCP engagement

Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if they are to bridge the gap between the value a compan

Partner Content